FDA Drug Application (020229) for LEUSTATIN by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number020229
Product Number001
FormINJECTABLE;INJECTION
Dosage1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLEUSTATIN
Active IngredientCLADRIBINE



Back to FDA Applications sponsored by JANSSEN PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.